nivolumab,ipilimumab
bms
['advanced l', 'ipi/', 'lung', 'diciple', 'nivo']
#esmo22 intriguing report by of the diciple study. 6 months vs continuous ipi/nivo for advanced lung ca. study only enrolled 1/4 of planned pts, but suggests shorter period is just fine. less cost, less side effects. good option for patients and payers if confirmed 
Associate Professor and Medical Oncologist at University of Ottawa, Past President of Lung Cancer Canada, and a cricket fan!